Clinical usefulness of very high serum soluble interleukin-2 receptor levels for the detection of tuberculous peritonitis in a patient with chronic myelogenous leukemia.

作者: Makoto Moriguchi , Hideo Koh , Tetsuya Hayashi , Hiroshi Okamura , Satoru Nanno

DOI: 10.1016/J.JIAC.2020.05.001

关键词:

摘要: Tuberculous peritonitis is difficult to diagnose due the disadvantages of ascitic culture and peritoneal biopsy. Although previous reports suggested that very high serum soluble interleukin-2 receptor (sIL-2R) levels may reflect clinical activity tuberculosis, little known about diagnostic utility sIL-2R for tuberculous peritonitis. We describe a case with chronic myelogenous leukemia. The abnormally value negative findings other possible causes including lymphoma we administered anti-tuberculosis treatment before definitive diagnosis. Abnormally contribute earlier diagnosis peritonitis, along ruling out potential differential diagnoses.

参考文章(42)
J M Porcel, M Vives, M C Rivas, M Rubio, B Pérez, I Gázquez, Diagnosis of tuberculous pleuritis by the measurement of soluble interleukin 2 receptor in pleural fluid. International Journal of Tuberculosis and Lung Disease. ,vol. 4, pp. 975- 979 ,(2000)
Jeffrey J. Molldrem, Peter P. Lee, Changqing Wang, Kyrie Felio, Hagop M. Kantarjian, Richard E. Champlin, Mark M. Davis, Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia Nature Medicine. ,vol. 6, pp. 1018- 1023 ,(2000) , 10.1038/79526
John L. Sullivan, Blake E. Tomkinson, David K. Wagner, David L. Nelson, Activated lymphocytes during acute Epstein-Barr virus infection. Journal of Immunology. ,vol. 139, pp. 3802- 3807 ,(1987)
Yi Ling Teo, Han Kiat Ho, Alexandre Chan, Metabolism‐related pharmacokinetic drug−drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations British Journal of Clinical Pharmacology. ,vol. 79, pp. 241- 253 ,(2015) , 10.1111/BCP.12496
Calogero Caruso, Giuseppina Candore, Diego Cigna, Antonio Tobia Colucci, Maria Assunta Modica, Biological significance of soluble IL-2 receptor Mediators of Inflammation. ,vol. 2, pp. 3- 21 ,(1993) , 10.1155/S0962935193000018
Anna Maria Witkowska, On the Role of sIL-2R Measurements in Rheumatoid Arthritis and Cancers Mediators of Inflammation. ,vol. 2005, pp. 121- 130 ,(2005) , 10.1155/MI.2005.121
E. M. RILEY, P. ROWE, S. J. ALLEN, B. M. GREENWOOD, Soluble plasma IL-2 receptors and malaria. Clinical and Experimental Immunology. ,vol. 91, pp. 495- 499 ,(2008) , 10.1111/J.1365-2249.1993.TB05930.X
Kosaku Komiya, Haruyuki Ariga, Hideaki Nagai, Shinji Teramoto, Atsuyuki Kurashima, Syunsuke Shoji, Yutsuki Nakajima, Impact of peripheral lymphocyte count on the sensitivity of 2 IFN-gamma release assays, QFT-G and ELISPOT, in patients with pulmonary tuberculosis. Internal Medicine. ,vol. 49, pp. 1849- 1855 ,(2010) , 10.2169/INTERNALMEDICINE.49.3659
Chhagan Bihari, Vikram Bhatia, Archana Rastogi, Vaishali Bhardwaj, Deepak Jain, Shalini Thapar, T-cell lymphoma with raised serum glycoprotein-125(CA-125) and raised ascitic fluid adenosinedeaminase levels initially presenting as ascites: a case report and review of literature. Diagnostic Cytopathology. ,vol. 39, pp. 770- 774 ,(2011) , 10.1002/DC.21551